Weight loss surgery alters fatty liver disease genes

Research has shown that weight loss surgery can benefit obese individuals in ways that go beyond shedding pounds, for example by causing early remission of type 2 diabetes. Now scientists have found that the surgery can also reverse the symptoms of fatty liver disease. The findings, which are to be published online on August 6 in the Cell Press journal Cell Metabolism, are derived from research on liver samples in normal and obese patients—some with fatty liver disease and some without fatty liver disease. The results provide another example of the DNA-altering effects of weight loss surgery.

Nonalcoholic (NAFLD)—which includes a spectrum of liver disorders in people with obesity and type 2 diabetes—is the most common chronic liver disorder in industrialized countries. NAFLD has emerged as one of the dominant types of liver disease worldwide and effects one in three Americans.

In an experimental tour de force, researchers analyzed liver samples from 27 obese individuals with different stages of NAFLD, 18 healthy obese individuals without liver disease, and 18 normal-weight individuals without liver disease. Methylation—a chemical modification on DNA that regulates gene expression—was altered on various genes in patients with NAFLD. The expression levels of nine of these genes—which code for key enzymes involved in metabolism and insulin signaling—were also different from those seen in healthy individuals. Furthermore, binding sites for proteins that affect gene expression were enriched in the liver disease patients' genes.

Dr. Joseph Hampe and his colleagues also found that when they compared patients' before and after weight loss surgery, the NAFLD-associated methylation changes were partially reversible. The findings demonstrate that changes the chemical properties of DNA, thereby affecting gene expression.

"These DNA modifications may point to the first steps in the evolution of the disease and may thus direct future research," says senior author Dr. Hampe of University Hospital Dresden, Germany. "In the very long term, they may lead to new therapeutic options."

More information: Cell Metabolism, Ahrens et al.: "DNA methylation analysis in non-alcoholic fatty liver disease suggests distinct disease-specific and remodelling signatures after bariatric surgery." dx.doi.org/10.1016/j.cmet.2013.07.004

Related Stories

NAFLD increases the risk of early atherosclerotic lesions

Apr 26, 2013

A study presented today at the International Liver Congress 2013 – which evaluated the relationship between non-alcoholic fatty liver disease (NAFLD), early predictors of atherosclerosis and the 10-year Framingham risk ...

Discovery of gene involved in fatty liver disease

Apr 24, 2013

An international research consortium led by CIC bioGUNE has discovered the involvement of a gene in the development of non-alcoholic fatty liver disease (NAFLD). Although the gene concerned (SLC2A1) had never previously been ...

Recommended for you

NY and NJ say they will require Ebola quarantines

10 hours ago

The governors of New Jersey and New York on Friday ordered a mandatory, 21-day quarantine for all doctors and other arriving travelers who have had contact with Ebola victims in West Africa.

WHO: Mali case may have infected many people

14 hours ago

The World Health Organization says a toddler who brought Ebola to Mali was bleeding from her nose during her journey on public transport and may have infected many people.

Two US nurses are declared cured of Ebola

15 hours ago

Two American nurses were declared cured of Ebola on Friday, and one was healthy enough to leave the hospital and meet President Barack Obama for a hug.

User comments